+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Type 2 Diabetes Treatment: Global Market Outlook - Product Thumbnail Image

Type 2 Diabetes Treatment: Global Market Outlook

  • Report
  • December 2022
  • 66 Pages
  • Global
From
Pre-Filled Syringes Market Report 2024-2034 - Product Thumbnail Image

Pre-Filled Syringes Market Report 2024-2034

  • Report
  • March 2024
  • 329 Pages
  • Global
From
LEVEMIR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LEVEMIR Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

IkappaB Kinase (IKK) Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Loading Indicator